NOS3 and cardiac hypertrophy: We demonstrated that one potential explanation may be due to impaired AKT/eNOS signalling in S1pr1‐deficient mice, as in vitro experiments showed that inhibition of AKT/eNOS reversed the inhibitory effect of S1pr1 on cardiac hypertrophy.